Detalles de la búsqueda
1.
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.
Biol Blood Marrow Transplant
; 26(12): 2365-2371, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32829080
2.
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(2): 262-271, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610237
3.
Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 25(12): 2522-2526, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31525493
4.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30716453
5.
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
Biol Blood Marrow Transplant
; 25(5): 955-964, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30605731
6.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30423480
7.
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica
; 104(4): 844-854, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30381298
8.
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1029-1034, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29369800
9.
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.
Biol Blood Marrow Transplant
; 24(6): 1187-1195, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410180
10.
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.
J Clin Apher
; 33(3): 303-309, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134688
11.
Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study.
Biol Blood Marrow Transplant
; 23(1): 165-171, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27751935
12.
Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study.
Biol Blood Marrow Transplant
; 23(9): 1567-1572, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533058
13.
Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 23(5): 776-781, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28108271
14.
The association of histologic grade with acute graft-versus-host disease response and outcomes.
Am J Hematol
; 92(7): 683-688, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28376566
15.
Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 22(6): 1141-1144, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26995694
16.
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(9): 1588-1595, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27343718
17.
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
Am J Hematol
; 91(4): 406-9, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26799334
18.
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Biol Blood Marrow Transplant
; 21(3): 552-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25528388
19.
Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.
Biol Blood Marrow Transplant
; 21(4): 640-5, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25528390
20.
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.
Blood
; 122(24): 3863-70, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24065243